Attovia Therapeutics, Inc. (ATTO)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
ATTO price, last 12 months
Key stats
- Previous close
- $15.58
- Open
- $15.40
- Day range
- $14.80 – $15.46
- 52-week range
- $12.94 – $28.00
- Volume
- 372.2K
- Avg volume (20 days)
- 259.3K
- Market cap
- $691.6M
Performance
Technicals and fundamentals
About Attovia Therapeutics, Inc.
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $691.6M